Neurological deficits caused by tissue hypoxia in neuroinflammatory disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Annals of Neurology

• Publication date

  2013-12-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1002/ana.24006PMID 24038279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination

  2013cited by this paper
• Increased expression of ER stress- and hypoxia-associated molecules in grey matter lesions in multiple sclerosis

  2012cited by this paper
• Chronic cerebrospinal venous insufficiency and multiple sclerosis: history and background.

  2012cited by this paper
• Oxygen-dependent regulation of nitric oxide production by inducible nitric oxide synthase.

  2011cited by this paper
• Radical changes in multiple sclerosis pathogenesis.

  2011influential reference
• The molecular basis of neurodegeneration in multiple sclerosis

  2011cited by this paper
• Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)

  2011cited by this paper
• Inflammatory Neurodegeneration and Mechanisms of Microglial Killing of Neurons

  2010cited by this paper
• Inflammation in neurodegenerative diseases

  2010cited by this paper
• Nitric oxide and neuronal death.

  2010cited by this paper
• Hypoxia‐inducible factor 1: a new hope to counteract neurodegeneration?

  2010cited by this paper
• Animal and human studies with the mitochondria‐targeted antioxidant MitoQ

  2010cited by this paper
• Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions

  2010cited by this paper
• Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter.

  2010cited by this paper
• Hyperbaric Oxygen Therapy for Multiple Sclerosis

  2010cited by this paper
• Molecular Changes in White Matter Adjacent to an Active Demyelinating Lesion in Early Multiple Sclerosis

  2009cited by this paper
• A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury

  2009cited by this paper
• Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression.

  2008cited by this paper
• Increased Expression of Endoplasmic Reticulum Stress-Related Signaling Pathway Molecules in Multiple Sclerosis Lesions

  2008cited by this paper
• Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection.

  2007cited by this paper
• Nitric oxide from neuronal nitric oxide synthase sensitises neurons to hypoxia‐induced death via competitive inhibition of cytochrome oxidase

  2007cited by this paper
• Chapter 12 – The pathology of multiple sclerosis

  2006cited by this paper
• Chronic hypoxia and the cerebral circulation.

  2006cited by this paper
• Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis.

  2005cited by this paper
• The pathology of multiple sclerosis.

  2005cited by this paper
• Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease?

  2005cited by this paper
• Nitric oxide from inflammatory‐activated glia synergizes with hypoxia to induce neuronal death

  2005cited by this paper
• Application of in vivo EPR in brain research: monitoring tissue oxygenation, blood flow, and oxidative stress

  2004cited by this paper
• A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions.

  2003cited by this paper
• Extraocular Blood Flow and Endothelin-1 Plasma Levels in Patients with Multiple Sclerosis

  2003cited by this paper
• Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic Insult

  2003cited by this paper
• Preferential Loss of Myelin‐Associated Glycoprotein Reflects Hypoxia‐Like White Matter Damage in Stroke and Inflammatory Brain Diseases

  2003cited by this paper
• Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α

  2003cited by this paper
• The role of nitric oxide in multiple sclerosis.

  2002cited by this paper
• Increased Endothelin-1 Plasma Levels in Patients With Multiple Sclerosis

  2001cited by this paper
• Oxygen Reduction by Nitric-oxide Synthases*

  2001cited by this paper
• Impact of endotoxin on UCP homolog mRNA abundance, thermoregulation, and mitochondrial proton leak kinetics.

  2000cited by this paper
• Lesion development in Marburg's type of acute multiple sclerosis: from inflammation to demyelination

  1999cited by this paper
• Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state.

  1998cited by this paper
• Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology

  1998cited by this paper
• Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible.

  1997cited by this paper
• The role of nitric oxide in multiple sclerosis

  1997influential reference
• Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.

  1996cited by this paper
• Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver.

  1995cited by this paper
• Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions.

  1994cited by this paper
• Energy metabolism of rabbit retina as related to function: high cost of Na+ transport

  1992cited by this paper
• Constitutive and inducible nitric oxide synthases incorporate molecular oxygen into both nitric oxide and citrulline.

  1991cited by this paper
• Hyperbaric oxygen therapy in multiple sclerosis

  1986cited by this paper
• Hyperbaric oxygen in the treatment of multiple sclerosis

  1985cited by this paper
• The respiratory burst of phagocytes.

  1984cited by this paper
• Criteria for an adequate explanation of typical clinical signs of EAE in rodents.

  1984cited by this paper
• Hyperbaric-oxygen treatment of multiple sclerosis. A randomized, placebo-controlled, double-blind study.

  1983cited by this paper
• Pathology of multiple sclerosis.

  1983cited by this paper
• Energy-requiring cell functions in the ischemic brain. Their critical supply and possible inhibition in protective therapy.

  1982cited by this paper
• Saltatory conduction precedes remyelination in axons demyelinated with lysophosphatidyl choline.

  1982cited by this paper
• Continuous conduction in demyelinated mammalian nerve fibres

  1976cited by this paper
• PHARMACOLOGICAL REDUCTION OF ABNORMALITY IN MULTIPLE SCLEROSIS WITHIN MINUTES: A STATISTICAL STUDY

  1958cited by this paper
• Phenomenon of relief by flush in multiple sclerosis; its use as a foundation for therapy.

  1955cited by this paper
• The clinical use of histamine.

  1951cited by this paper
• Multiple sclerosis; treatment with histamine and d-tubocurarine.

  1948cited by this paper

• Hypoxia-Inducible Factor 1-α in Autoimmune Diseases-Insights from the Paradigm of Hashimoto's Thyroiditis: A Narrative Review.

  2026cites this paper
• Neurodegeneration and Demyelination in the Multiple Sclerosis Spinal Cord

  2025cites this paper
• Investigation of neuro‐vascular reactivity on fMRI study during visual activation in people with multiple sclerosis using EEG and hypercapnia challenge

  2025cites this paper
• Lamina Cribrosa Hypoxia Sensitivity to Variations of Anatomy and Vascular Factors.

  2025cites this paper
• Hypoxia in multiple sclerosis

  2025influential citation
• Innate Immunity Reimagined: Metabolic Reprogramming as a Gateway to Novel Therapeutics

  2025cites this paper
• Continuous Positive Airway Pressure and Progression of Enlarged Perivascular Spaces in Adults With Obstructive Sleep Apnea.

  2025cites this paper
• Treatment of Mitochondrial Disturbances due to Early Life Adversity in Mice Results in Restoration of Complex I Activity and Normal Reward Behavior

  2025cites this paper
• The neuropathobiology of multiple sclerosis

  2024cites this paper
• Spinal cord perfusion impairments in the M83 mouse model of Parkinson’s disease

  2024cites this paper
• The Robust Lamina Cribrosa Vasculature: Perfusion and Oxygenation Under Elevated Intraocular Pressure

  2024cites this paper
• Tissue Hypoxia and Associated Innate Immune Factors in Experimental Autoimmune Optic Neuritis

  2024influential citation
• Regulation of stress granule formation in human oligodendrocytes

  2024cites this paper
• Staining Hypoxic Areas of Frozen and FFPE Tissue Sections with Hypoxyprobe™.

  2024cites this paper
• Novel perfluorocarbon-based oxygenation therapy alleviates Post-SAH hypoxic brain injury by inhibiting HIF-1α.

  2024cites this paper
• A Hypoxia-Inflammation Cycle and Multiple Sclerosis: Mechanisms and Therapeutic Implications

  2024cites this paper
• Spiral volumetric optoacoustic tomography of reduced oxygen saturation in the spinal cord of M83 mouse model of Parkinson’s disease

  2024cites this paper
• Impact of anatomic variability and other vascular factors on lamina cribrosa hypoxia

  2024cites this paper
• From BBB to PPP: Bioenergetic requirements and challenges for oligodendrocytes in health and disease

  2024cites this paper
• Watershed regions are more susceptible to tissue microstructural injury in multiple sclerosis.

  2024cites this paper
• Nimodipine Protects Vascular and Cognitive Function in an Animal Model of Cerebral Small Vessel Disease

  2024cites this paper
• Investigating cortical hypoxia in multiple sclerosis via time‐domain near‐infrared spectroscopy

  2024cites this paper
• Relationship between Hypoxic and Immune Pathways Activation in the Progression of Neuroinflammation: Role of HIF-1α and Th17 Cells

  2023cites this paper
• ДОСЛІДЖЕННЯ АСОЦІАЦІЙ МІЖ ПОЛІМОРФІЗМОМ G308A ГЕНА TNFα ТА КЛІНІКО-НЕВРОЛОГІЧНИМИ, НЕЙРОВІЗУАЛІЗАЦІЙНИМИ, ГЕМОДИНАМІЧНИМИ ХАРАКТЕРИСТИКАМИ І КОГНІТИВНОЮ ДИСФУНКЦІЄЮ У ПАЦІЄНТІВ ІЗ СУДИННОЮ ЕНЦЕФАЛОПАТІЄЮ ПРИ ХРОНІЧНІЙ ІШЕМІЇ МОЗКУ

  2023cites this paper
• Non-Invasive Evaluation of Retinal Vascular Alterations in a Mouse Model of Optic Neuritis Using Laser Speckle Flowgraphy and Optical Coherence Tomography Angiography

  2023cites this paper
• Temporal Pattern of Cortical Hypoxia in Multiple Sclerosis and Its Significance on Neuropsychological and Clinical Measures of Disability

  2023cites this paper
• Regional contribution of vascular dysfunction in white matter dementia: clinical and neuropathological insights

  2023cites this paper
• HIF prolyl hydroxylase 2/3 deletion disrupts astrocytic integrity and exacerbates neuroinflammation

  2023influential citation
• Nose to brain delivery of ibudilast micelles for treatment of multiple sclerosis in an experimental autoimmune encephalomyelitis animal model.

  2023cites this paper
• How does neurovascular unit dysfunction contribute to multiple sclerosis?

  2023cites this paper
• Cerebrovascular Reactivity and Neurovascular Coupling in Multiple Sclerosis—A Systematic Review

  2022cites this paper
• Non-invasive Detection of Persistent Cortical Hypoxia in Multiple Sclerosis Using Frequency Domain Near-Infrared Spectroscopy (fdNIRS).

  2022cites this paper
• Oxygen treatment reduces neurological deficits and demyelination in two animal models of multiple sclerosis

  2022influential citation
• Effect of β-hydroxybutyrate on behavioral alterations, molecular and morphological changes in CNS of multiple sclerosis mouse model

  2022cites this paper
• Chronic oligodendrocyte injury in central nervous system pathologies

  2022cites this paper
• Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis

  2022cites this paper
• Pattern ERGs suggest a possible retinal contribution to the visual acuity loss in acute optic neuritis

  2022cites this paper
• Reduced brain oxygen metabolism in patients with multiple sclerosis: Evidence from dual-calibrated functional MRI

  2022cites this paper
• Thyroid hormone-dependent oligodendroglial cell lineage genomic and non-genomic signaling through integrin receptors

  2022cites this paper
• Association of Cerebral Small Vessel Disease With Gait and Balance Disorders

  2022cites this paper
• Clinical, Radiological and Pathological Characteristics Between Cerebral Small Vessel Disease and Multiple Sclerosis: A Review

  2022cites this paper
• Neuroinflammation in Vascular Cognitive Impairment and Dementia: Current Evidence, Advances, and Prospects

  2022cites this paper
• Eye-specific 3D modeling of factors influencing oxygen concentration in the lamina cribrosa.

  2022cites this paper
• Pharmacological significance of MitoQ in ameliorating mitochondria-related diseases

  2022cites this paper
• Mapping of neuroinflammation-induced hypoxia in the spinal cord using optoacoustic imaging

  2022cites this paper
• Epigallocatechin Gallate Protects against Hypoxia-Induced Inflammation in Microglia via NF-κB Suppression and Nrf-2/HO-1 Activation

  2022cites this paper
• Smouldering multiple sclerosis: the ‘real MS’

  2022cites this paper
• Regulated cell death: discovery, features and implications for neurodegenerative diseases

  2021cites this paper
• Susceptibility weighted imaging detects prominent veins that precede or coincide with maximal motor disability in a model of multiple sclerosis: A pilot study.

  2021cites this paper
• The Critical Importance of Molecular Biomarkers and Imaging in the Study of Electrohypersensitivity. A Scientific Consensus International Report

  2021cites this paper
• Multiple Roles of Peripheral Immune System in Modulating Ischemia/Hypoxia-Induced Neuroinflammation

  2021cites this paper
• Hypoxia, Acidification and Inflammation: Partners in Crime in Parkinson’s Disease Pathogenesis?

  2021cites this paper
• Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study.

  2021cites this paper
• Hypoxia response element-directed expression of bFGF in dental pulp stem cells improve the hypoxic environment by targeting pericytes in SCI rats

  2021cites this paper
• Using dual-calibrated functional MRI to map brain oxygen supply and consumption in multiple sclerosis

  2021cites this paper
• Retinal Oxygen Metabolism and Haemodynamics in Patients With Multiple Sclerosis and History of Optic Neuritis

  2021cites this paper
• The role of complex IV activity in the axonal response of mitochondria to demyelination in experimental disease models of multiple sclerosis

  2021cites this paper
• Serum HGF and APN2 are associated with disability worsening in SPMS.

  2021cites this paper
• Magnetic Resonance Imaging and Clinical Features of the Demyelinating Degeneration of White Matter in Young Patients

  2021cites this paper
• Propofol Attenuates Hypoxia-Induced Inflammation in BV2 Microglia by Inhibiting Oxidative Stress and NF-κB/Hif-1α Signaling

  2020cites this paper
• Mitochondrial Dysfunction in EAE Mice Brains and Impact of HIF1-α Induction to Compensate Energy Loss

  2020cites this paper
• Chronic mild hypoxia accelerates recovery from preexisting EAE by enhancing vascular integrity and apoptosis of infiltrated monocytes

  2020cites this paper
• Nimodipine Reduces Dysfunction and Demyelination in Models of Multiple Sclerosis

  2020cites this paper
• Multi-spectral vascular oximetry of rat dorsal spinal cord

  2020cites this paper
• Anterior visual system imaging to investigate energy failure in multiple sclerosis.

  2020cites this paper
• Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis

  2020cites this paper
• Imaging and therapy in multiple sclerosis

  2020cites this paper
• Hypoxia in multiple sclerosis; is it the chicken or the egg?

  2020cites this paper
• Optical Coherence Tomography Angiography (OCTA) in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

  2020cites this paper
• Low-cost, multispectral imaging mini-microscope for longitudinal oximetry in small animals.

  2019cites this paper
• Hypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunction.

  2019cites this paper
• Temporal evolution of acute multiple sclerosis lesions on serial sodium (23Na) MRI.

  2019cites this paper
• The role of glial-neuronal metabolic cooperation in modulating progression of multiple sclerosis and neuropathic pain.

  2019cites this paper
• Regulation of sirtuin expression in autoimmune neuroinflammation: Induction of SIRT1 in oligodendrocyte progenitor cells.

  2019cites this paper
• Mitochondrial Targeting of Antioxidants Alters Pancreatic Acinar Cell Bioenergetics and Determines Cell Fate

  2019cites this paper
• Vascular aspects of multiple sclerosis: emphasis on perfusion and cardiovascular comorbidities

  2019influential citation
• A role for spinal cord hypoxia in neurodegeneration

  2019cites this paper
• Niche-selective inhibition of pathogenic Th17 cells by targeting metabolic redundancy

  2019cites this paper
• Expanding the Potential Therapeutic Options for Remote Ischemic Preconditioning: Use in Multiple Sclerosis

  2018cites this paper
• Understanding the role of the perivascular space in cerebral small vessel disease

  2018cites this paper
• Hypoxic pre-conditioning suppresses experimental autoimmune encephalomyelitis by modifying multiple properties of blood vessels

  2018cites this paper
• Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years

  2018cites this paper
• Targeting pericytes for therapeutic approaches to neurological disorders

  2018cites this paper
• Multiple sclerosis disease progression: Contributions from a hypoxia–inflammation cycle

  2018cites this paper
• Experimental autoimmune encephalomyelitis from a tissue energy perspective

  2017cites this paper
• Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis

  2017cites this paper
• Snapshot multispectral oximetry using image replication and birefringent spectrometry

  2017influential citation
• Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier

  2017cites this paper
• Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis

  2017cites this paper
• Mitochondrial function and dynamics in demyelinated axons

  2017cites this paper
• The Niels Lassen Award Session and Oral Sessions

  2017cites this paper
• Exploring the role of hypoxia in neuroinflammatory disease and the use of oxygen as a therapy

  2017influential citation
• Age‐related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis

  2017cites this paper
• Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System

  2017cites this paper
• Nogo-A Antibodies for Progressive Multiple Sclerosis

  2017cites this paper
• Mitochondria-targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis.

  2017cites this paper
• Mitochondria in neuroinflammation - Multiple sclerosis (MS), leber hereditary optic neuropathy (LHON) and LHON-MS.

  2017cites this paper
• Minimally invasive optical biopsy for oximetry

  2017cites this paper
• Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis?

  2017cites this paper
• A multispectral microscope for in vivo oximetry of rat dorsal spinal cord vasculature

  2017cites this paper